Skip to main content
. 2024 Jun 17;25:388. doi: 10.1186/s13063-024-08196-5
Title {1} SCANPatient: Study protocol for a multi-centre, batched, stepped wedge, comparative effectiveness, randomised clinical trial of synoptic reporting of computerised tomography (CT) scans assessing cancer of the pancreas.
Trial registration {2a and 2b} The SCANPatient trial has been registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) (ACTRN12623000508673).
Protocol version {3} 3 November 2023, Protocol V1.3.
Funding {4} Funded by the Australian Government’s Medical Research Future Fund (MRFF) Rare Cancers, Rare Diseases and Unmet Need grant awarded to Monash University (MRF2015163).
Author details {5a}

1School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.

2Monash Program, Alfred Health, Victoria

3Department of Surgery, Western Sydney University, NSW

4Department of Surgery, Royal Brisbane and Women’s Hospital, QLD

5Department of Radiology, Alfred Health, Victoria

6CRP Consumer Reference Group, Monash University, Victoria

7Department of Cancer Imaging, The Peter MacCallum Cancer Centre, Melbourne, Victoria

8The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria

9Department of Medical Oncology, Wollongong Hospital, NSW

10Faculty of Science, Medicine and Health, University of Wollongong, NSW

11Department of Surgery, Royal Melbourne Hospital, Victoria

12Department of Surgery, Austin health, Victoria

13Department of Surgery, Monash Medical Centre, Victoria

14Department of Radiology, Concord Hospital, NSW

15SA Node National Imaging Facility, Flinders Medical Centre, SA

16Department of Surgery, Alfred Health, Victoria, Australia.

Name and contact information for the trial sponsor {5b}

SCANPatient Research Fellow, Cancer Research Program,

School of Public Health and Preventive Medicine

Monash University

Level 5, 553 St Kilda Road, Melbourne VIC 3004, Australia

Tel: + 61 (3) 9903 0378

Email: SCANPatient@monash.edu

Role of sponsor {5c} This is an investigator initiated clinical trial. The funder played no role in study design; collection, management, analysis, and interpretation of data; writing of the manuscript; and the decision to submit the manuscript for publication, and they will have no ultimate authority over any of these activities.